Brendan P. Eckelman
2019
In 2019, Brendan P. Eckelman earned a total compensation of $679K as Chief Scientific Officer at Inhibrx.
Compensation breakdown
| Non-Equity Incentive Plan | $140,000 |
|---|---|
| Salary | $350,000 |
| Other | $189,000 |
| Total | $679,000 |
Eckelman received $350K in salary, accounting for 52% of the total pay in 2019.
Eckelman also received $140K in non-equity incentive plan and $189K in other compensation.
Rankings
In 2019, Brendan P. Eckelman's compensation ranked 10,798th out of 13,971 executives tracked by ExecPay. In other words, Eckelman earned more than 22.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,798 out of 13,971 | 23rd |
Division Manufacturing | 4,369 out of 5,701 | 23rd |
Major group Chemicals And Allied Products | 1,702 out of 2,200 | 23rd |
Industry group Drugs | 1,458 out of 1,886 | 23rd |
Industry Biological Products, Except Diagnostic Substances | 327 out of 389 | 16th |
Source: SEC filing on April 28, 2021.
Eckelman's colleagues
We found two more compensation records of executives who worked with Brendan P. Eckelman at Inhibrx in 2019.